Chemotherapy can improve survival and palliate symptoms of unresectable advanced or recurrent colorectal cancer, and combined administration of a cytotoxic anticancer drug and molecular-targeted therapy, such as vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) inhibitors [1]. Here, EGFR is linked to colorectal cancer.